|
answer text |
<p>Brain tumours can commonly refer to a range of different conditions depending on
the type of tumour. They are also grouped with other central nervous system tumours
when being recorded. As such it is not possible for us to isolate brain tumours as
a separate recorded condition. The available information held relating to this condition
is shown in the following tables:</p><p><strong>Table 1: Number of individuals making
an initial claim to Employment and Support Allowance (ESA) whose main disabling condition
was recorded as relating to Brain or Central Nervous System Tumours, by year of claim
start Jan 2010 to Mar 2017: Great Britain</strong></p><table><tbody><tr><td><p><strong>Year
of ESA </strong> <strong>claim start</strong></p></td><td><p><strong>Initial ESA<br>
claims</strong></p></td></tr><tr><td><p><strong>2010</strong></p></td><td><p>1,000</p></td></tr><tr><td><p><strong>2011</strong></p></td><td><p>1,200</p></td></tr><tr><td><p><strong>2012</strong></p></td><td><p>1,100</p></td></tr><tr><td><p><strong>2013</strong></p></td><td><p>1,200</p></td></tr><tr><td><p><strong>2014</strong></p></td><td><p>1,200</p></td></tr><tr><td><p><strong>2015</strong></p></td><td><p>1,100</p></td></tr><tr><td><p><strong>2016</strong></p></td><td><p>1,200</p></td></tr><tr><td><p><strong>2017
(Jan - Mar)</strong></p></td><td><p>300</p></td></tr></tbody></table><p> </p><p><strong>Table
2: Number of individuals assigned to the ESA Support Group or the ESA Work Capability
Group following their Work Capability Assessment (for initial, repeat or IB reassessment
claims), whose main disabling condition was recorded as relating to Brain or Central
Nervous System Tumours, by year of claim start or IB reassessment referral, Jan 2010
to Mar 2017: Great Britain</strong></p><table><tbody><tr><td><p><strong>Year of ESA
claim start</strong></p></td><td><p><strong>Initial ESA<br> claims</strong></p></td><td><p><strong>Repeat
ESA<br> assessments</strong></p></td><td><p><strong>IB<br> reassessments</strong></p></td></tr><tr><td><p><strong>2010</strong></p></td><td><p>800</p></td><td><p>400</p></td><td><p>-</p></td></tr><tr><td><p><strong>2011</strong></p></td><td><p>900</p></td><td><p>600</p></td><td><p>300</p></td></tr><tr><td><p><strong>2012</strong></p></td><td><p>900</p></td><td><p>600</p></td><td><p>600</p></td></tr><tr><td><p><strong>2013</strong></p></td><td><p>900</p></td><td><p>500</p></td><td><p>700</p></td></tr><tr><td><p><strong>2014</strong></p></td><td><p>900</p></td><td><p>300</p></td><td><p>100</p></td></tr><tr><td><p><strong>2015</strong></p></td><td><p>900</p></td><td><p>200</p></td><td><p>100</p></td></tr><tr><td><p><strong>2016</strong></p></td><td><p>800</p></td><td><p>100</p></td><td><p>100</p></td></tr><tr><td><p><strong>2017
(Jan - Mar)</strong></p></td><td><p>200</p></td><td><p>-</p></td><td><p>-</p></td></tr></tbody></table><p>
</p><p><strong>Source for Tables 1 and 2:</strong> Application data is derived from
administrative data held by the DWP and assessment data provided by the Healthcare
Provider.</p><p><strong>Notes for Tables 1 and 2:</strong></p><ol><li>The figures
are rounded to the nearest 100. “–” denotes figures that are zero or less than 50.</li><li>The
information for 2017 is provided up to March 2017 only; this is the latest data available
at time of request.</li><li>National roll-out of IB reassessments began in March 2011.
As a result, the 2011 figures for IB reassessment in Table 2 cover the period from
March to December.</li><li>An individual may have made more than one ESA claim or
assessment in any given year. These individuals will only be counted once in each
of the figures provided.</li><li>The following groupings have been included in this
analysis:</li></ol><p>a. Malignant Neoplasm of Brain</p><p>b. Benign Neoplasm of Meninges</p><p>c.
Benign Neoplasm of Brain and other parts of central nervous system</p><p>d. Neoplasm
of uncertain or unknown behaviour of brain and central nervous system</p><p>6. The
primary medical condition recorded on the claim form does not itself confer entitlement
to ESA. So, for example, a decision on entitlement for a customer claiming ESA on
the basis of Malignant Neoplasm of Brain would be based on their ability to carry
out the range of activities assessed by the work capability assessment.</p><p> </p>
|
|